Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Paolo F. Caimi, Brenda W. Cooper, Basem M. William, Afshin Dowlati, Paul M. Barr, Pingfu Fu, John Pink, Yan Xu, Hillard M. Lazarus, Marcos de Lima, Stanton L. Gerson
Published Aug 9, 2017 · Vol. 8, No. 45 · pp. 79864-79875
Stefan M. Brunner, Timo Itzel, Christoph Rubner, Rebecca Kesselring, Eva Griesshammer, Matthias Evert, Andreas Teufel, Hans J. Schlitt, Stefan Fichtner-Feigl
Published Aug 9, 2017 · Vol. 8, No. 41 · pp. 71002-71011
Raphael B. Moreira, Marcio Debiasi, Edoardo Francini, Pier V. Nuzzo, Guillermo De Velasco, Fernando C. Maluf, Andre P. Fay, Joaquim Bellmunt, Toni K. Choueiri, Fabio A. Schutz
Published Aug 8, 2017 · Vol. 8, No. 48 · pp. 84572-84578
